Range Yourself

Oak GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Oak review — semaglutide compounded — advertised from $119/mo (promo); recurring rate not consistently listed, confirm in enrollment, tirzepatide compounded — advertised from $185/mo (promo); recurring rate not consistently listed, confirm in enrollment. Compounded GLP-1 shoppers comparing cash-pay options. Independent 2026 review from RangeYourself.

Quick take

Oak is compounded semaglutide and tirzepatide — injectable and sublingual (oak longevity), priced as cash-pay subscription; recurring price not consistently listed publicly (advertised $119–$190/mo under promos). Best for: Compounded GLP-1 shoppers comparing cash-pay options. Watch out for: Oak advertises figures from $119 to $190/mo across its own pages under promotions and does not list one consistent recurring price — confirm the exact ongoing rate in the enrollment flow before subscribing. Fees are non-refundable once charged.

Pricing summary

  • Price verified: (checked against the provider’s public pricing surface)
  • All-in monthly cost: Not publicly listed — shown after intake
  • Semaglutide: Compounded — advertised from $119/mo (promo); recurring rate not consistently listed, confirm in enrollment
  • Tirzepatide: Compounded — advertised from $185/mo (promo); recurring rate not consistently listed, confirm in enrollment
  • Compounded vs brand-name: Compounded only
  • Insurance accepted: No (cash-pay only)
  • Consult type: Async (questionnaire-based)
  • Dose-escalation pricing: Not consistently disclosed publicly — Oak advertises $119–$190/mo across its own pages; confirm your dose's rate in the enrollment flow.
  • Refund policy: Non-refundable: Oak's Terms of Use state fees 'ARE NOT REFUNDABLE IN WHOLE OR IN PART'; the auto-renewing subscription can be cancelled anytime (best-efforts within 24h).
  • States served: 45 states — confirm your state at signup

Check Oak pricing

Choose Oak if

  • You want compounded semaglutide or tirzepatide (injectable or sublingual) on a cash-pay plan
  • You're comfortable confirming the exact recurring price in Oak's enrollment flow rather than on the public site
  • You prefer async care with no video visit required
  • You want same-day provider review and free shipping

Skip Oak if

You want a single clearly-listed recurring price up front, insurance billing, or a refund option.

Contraindications and clinical notes

Standard GLP-1 contraindications per GLP-1 prescribing information (personal/family history of MTC or MEN 2). Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

How Oak compares

Frequently asked questions

How much does Oak cost per month?

Oak does not publish pricing publicly — you only see your monthly cost after creating an account and completing the intake assessment. Not consistently disclosed publicly — Oak advertises $119–$190/mo across its own pages; confirm your dose's rate in the enrollment flow.

Does Oak accept insurance?

No. Oak operates as cash-pay only. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does Oak serve?

Oak serves 45 states — confirm your state at signup.

Is Oak compounded or brand-name?

Oak prescribes compounded semaglutide and tirzepatide via state-licensed compounding pharmacies. Compounded medication is legal under FDA guidance during drug shortages and for individual patient prescriptions, but is not individually FDA-approved.

What's the catch with Oak?

Oak advertises figures from $119 to $190/mo across its own pages under promotions and does not list one consistent recurring price — confirm the exact ongoing rate in the enrollment flow before subscribing. Fees are non-refundable once charged. Avoid if: you want a single clearly-listed recurring price up front, insurance billing, or a refund option.

Related guides

RangeYourself is reader-supported. We may earn a commission when you click on certain links — at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers verified on 2026-07-12 and may change.